SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Md. Kaimul Ahsan, Wajahat Z. Mehal, Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb, Frontiers in Pharmacology, 2014, 5,

    CrossRef

  2. 2
    Manling Zhou, Xuhui Zhu, Siying Ye, Biyun Zhou, Blocking TLR2 in vivo attenuates experimental hepatitis induced by concanavalin A in mice, International Immunopharmacology, 2014, 21, 1, 241

    CrossRef

  3. 3
    Wajahat Z. Mehal, Constitutive NLRP3 activation: Too much of a bad thing, Hepatology, 2014, 59, 3
  4. 4
    Fan-rong Wu, Chun-xiao Pan, Chao Rong, Quan Xia, Feng-lai Yuan, Jie Tang, Xiao-yu Wang, Nan Wang, Wen-lin Ni, Fei-hu Chen, Inhibition of acid-sensing ion channel 1a in hepatic stellate cells attenuates PDGF-induced activation of HSCs through MAPK pathway, Molecular and Cellular Biochemistry, 2014, 395, 1-2, 199

    CrossRef

  5. 5
    Alfred C. Aplin, Giovanni Ligresti, Eric Fogel, Penelope Zorzi, Kelly Smith, Roberto F. Nicosia, Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by Toll-like receptors, Angiogenesis, 2014, 17, 1, 147

    CrossRef

  6. 6
    Nobuhiro Nakamoto, Takanori Kanai, Role of Toll-Like Receptors in Immune Activation and Tolerance in the Liver, Frontiers in Immunology, 2014, 5,

    CrossRef

  7. 7
    Eda K. Holl, Jennifer E. Bond, Maria A. Selim, Tosan Ehanire, Bruce Sullenger, Howard Levinson, The Nucleic Acid Scavenger Polyamidoamine Third-Generation Dendrimer Inhibits Fibroblast Activation and Granulation Tissue Contraction, Plastic and Reconstructive Surgery, 2014, 134, 3, 420e

    CrossRef

  8. 8
    J-P Pradere, D H Dapito, R F Schwabe, The Yin and Yang of Toll-like receptors in cancer, Oncogene, 2014, 33, 27, 3485

    CrossRef

  9. 9
    Yoon Seok Roh, Surim Park, Jong Won Kim, Chae Woong Lim, Ekihiro Seki, Bumseok Kim, Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis, Hepatology, 2014, 60, 1
  10. 10
    M. Shimada, J. Cheng, A. Sanyal, Pathobiology of Human Disease, 2014,

    CrossRef

  11. 11
    Xinshou Ouyang, Ayaz Ghani, Ahsan Malik, Tuere Wilder, Oscar Rene Colegio, Richard Anthony Flavell, Bruce Neil Cronstein, Wajahat Zafar Mehal, Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1α pathway, Nature Communications, 2013, 4,

    CrossRef

  12. 12
    Catherine Brenner, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer, Decoding cell death signals in liver inflammation, Journal of Hepatology, 2013, 59, 3, 583

    CrossRef

  13. 13
    Alexander Wree, Lori Broderick, Ali Canbay, Hal M. Hoffman, Ariel E. Feldstein, From NAFLD to NASH to cirrhosis—new insights into disease mechanisms, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 627

    CrossRef

  14. 14
    Yizhong Wang, Jieliang Li, Xu Wang, Min Sang, Wenzhe Ho, Hepatic stellate cells, liver innate immunity, and hepatitis C virus, Journal of Gastroenterology and Hepatology, 2013, 28,
  15. 15
    Y. Wang, J. Li, X. Wang, L. Ye, Y. Zhou, W. Ho, Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell–mediated hepatitis C virus inhibition in hepatocytes, Journal of Viral Hepatitis, 2013, 20, 6
  16. 16
    Joy X. Jiang, Natalie J. Török, Liver Injury and the Activation of the Hepatic Myofibroblasts, Current Pathobiology Reports, 2013, 1, 3, 215

    CrossRef

  17. 17
    Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough, Jan G. Hengstler, Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME, Archives of Toxicology, 2013, 87, 8, 1315

    CrossRef

  18. 18
    Peter Huebener, Robert F. Schwabe, Regulation of wound healing and organ fibrosis by toll-like receptors, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 7, 1005

    CrossRef

  19. 19
    Rafaz Hoque, Yoram Vodovotz, Wajahat Mehal, Therapeutic strategies in inflammasome mediated diseases of the liver, Journal of Hepatology, 2013, 58, 5, 1047

    CrossRef

  20. 20
    Yoon Seok Roh, Ekihiro Seki, Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis, Journal of Gastroenterology and Hepatology, 2013, 28,
  21. 21
    Jessica Howell, Peter Angus, Paul Gow, Kumar Visvanathan, Toll-like receptors in hepatitis C infection: Implications for pathogenesis and treatment, Journal of Gastroenterology and Hepatology, 2013, 28, 5
  22. 22
    Maria J. Perugorria, Lindsay B. Murphy, Nicola Fullard, Jayashree B. Chakraborty, Dimitra Vyrla, Caroline L. Wilson, Fiona Oakley, Jelena Mann, Derek A. Mann, Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor–induced TIMP-1 gene transcription in hepatic stellate cells in mice, Hepatology, 2013, 57, 3
  23. 23
    Jan Petrasek, Timea Csak, Gyongyi Szabo, 2013,

    CrossRef

  24. 24
    Azuma Watanabe, Muhammad Adnan Sohail, Samir Gautam, Dawidson Assis Gomes, Wajahat Zafar Mehal, Adenine Induces Differentiation of Rat Hepatic Stellate Cells, Digestive Diseases and Sciences, 2012, 57, 9, 2371

    CrossRef

  25. 25
    Petros C. Benias, Kavitha Gopal, Henry Bodenheimer, Neil D. Theise, Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 5, 448

    CrossRef

  26. 26
    Megan Crane, Kumar Visvanathan, Sharon R. Lewin, HIV Infection and TLR Signalling in the Liver, Gastroenterology Research and Practice, 2012, 2012, 1

    CrossRef

  27. 27
    Hajime Tanaka, Patrick S. C. Leung, Tom P. Kenny, M. Eric Gershwin, Christopher L. Bowlus, Immunological Orchestration of Liver Fibrosis, Clinical Reviews in Allergy & Immunology, 2012, 43, 3, 220

    CrossRef

  28. 28
    Ruonan Xu, Zheng Zhang, Fu-Sheng Wang, Liver fibrosis: mechanisms of immune-mediated liver injury, Cellular and Molecular Immunology, 2012, 9, 4, 296

    CrossRef

  29. 29
    Jayashree Bagchi Chakraborty, Fiona Oakley, Meagan J. Walsh, Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  30. 30
    E. Ballot, E. Beleoken, M.Z. Mustafa, C. Johanet, J.-C. Duclos-Vallée, Relations entre foie et immunité, EMC - Hépatologie, 2012, 7, 3, 1

    CrossRef

  31. 31
    Ming-Huei Chou, Ying-Hsien Huang, Tsun-Mei Lin, Yung-Ying Du, Po-Chin Tsai, Chih-Sung Hsieh, Jiin-Haur Chuang, Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype, Biochemical Journal, 2012, 447, 1, 25

    CrossRef

  32. 32
    Naim Alkhouri, Christine Carter-Kent, Ariel E Feldstein, Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications, Expert Review of Gastroenterology & Hepatology, 2011, 5, 2, 201

    CrossRef

  33. 33
    Ning Yu, Shujie Zhang, Tao Sun, Kefei Kang, Ming Guan, Leihong Xiang, Double-stranded RNA induces melanocyte death via activation of Toll-like receptor 3, Experimental Dermatology, 2011, 20, 2
  34. 34
    R. K. Gieseler, G. Marquitan, M. Schlattjan, J.-P. Sowa, L. P. Bechmann, J. Timm, M. Roggendorf, G. Gerken, S. L. Friedman, A. Canbay, Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C, Journal of Viral Hepatitis, 2011, 18, 11
  35. 35
    Ursula E. Lee, Scott L. Friedman, Mechanisms of hepatic fibrogenesis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 195

    CrossRef

  36. 36
    Tom Luedde, Robert F. Schwabe, NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 2, 108

    CrossRef

  37. 37
    Virginia Hernandez-Gea, Scott L. Friedman, Pathogenesis of Liver Fibrosis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 425

    CrossRef

  38. 38
    Shen-Nien Wang, Sen-Te Wang, King Teh Lee, The Potential Interplay of Adipokines with Toll-Like Receptors in the Development of Hepatocellular Carcinoma, Gastroenterology Research and Practice, 2011, 2011, 1

    CrossRef

  39. 39
    Tracy R Luckhardt, Stephanie M Coomes, Glenda Trujillo, Joshua S Stoolman, Kevin M Vannella, Urvashi Bhan, Carol A Wilke, Thomas A Moore, Galen B Toews, Cory Hogaboam, Bethany B Moore, TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis, Fibrogenesis & Tissue Repair, 2011, 4, 1, 18

    CrossRef

  40. 40
    Yongyan Chen, Rui Sun, Toll-like receptors in acute liver injury and regeneration, International Immunopharmacology, 2011, 11, 10, 1433

    CrossRef

  41. 41
    Ekihiro Seki, EekJoong Park, Jiro Fujimoto, Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis, Hepatology Research, 2011, 41, 7
  42. 42
    Jan Petrasek, Angela Dolganiuc, Timea Csak, Evelyn A. Kurt–Jones, Gyongyi Szabo, Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice, Gastroenterology, 2011, 140, 2, 697

    CrossRef

  43. 43
    Jing-Hua Wang, Jang-Woo Shin, Jin-Young Son, Jung-Hyo Cho, Chang-Gue Son, Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats, Journal of Ethnopharmacology, 2010, 127, 2, 534

    CrossRef

  44. 44
    Jang-Woo Shin, Jing-Hua Wang, Jong-Koo Kang, Chang-Gue Son, Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats, Journal of the Science of Food and Agriculture, 2010, 90, 3
  45. 45
    Ruth M. L. De Bruyne, Emer Fitzpatrick, Anil Dhawan, Fatty liver disease in children: eat now pay later, Hepatology International, 2010, 4, 1, 375

    CrossRef

  46. 46
    Bin Gao, Innate Immunity and Steatohepatitis: A Critical Role of Another Toll (TLR-9), Gastroenterology, 2010, 139, 1, 27

    CrossRef

  47. 47
    Joy X. Jiang, Senthil Venugopal, Nobuko Serizawa, Xiangling Chen, Fiona Scott, Yong Li, Roger Adamson, Sridevi Devaraj, Vijay Shah, M. Eric Gershwin, Scott L. Friedman, Natalie J. Török, Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo, Gastroenterology, 2010, 139, 4, 1375

    CrossRef

  48. 48
    Kouichi Miura, Ekihiro Seki, Hirohide Ohnishi, David A. Brenner, Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  49. 49
    M. Kern, A. Popov, C. Kurts, J.L. Schultze, P.A. Knolle, Taking off the brakes: T cell immunity in the liver, Trends in Immunology, 2010, 31, 8, 311

    CrossRef

  50. 50
    Sophie Clément, Stéphanie Pascarella, Stéphanie Conzelmann, Carmen Gonelle-Gispert, Kévin Guilloux, Francesco Negro, The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8, Journal of Hepatology, 2010, 52, 5, 635

    CrossRef

  51. 51
    Amelie E. Bigorgne, Ian Nicholas Crispe, TLRs in Hepatic Cellular Crosstalk, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  52. 52
    Kouichi Miura, Yuzo Kodama, Sayaka Inokuchi, Bernd Schnabl, Tomonori Aoyama, Hirohide Ohnishi, Jerrold M. Olefsky, David A. Brenner, Ekihiro Seki, Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice, Gastroenterology, 2010, 139, 1, 323

    CrossRef

  53. 53
    Tomonori Aoyama, Yong-Han Paik, Ekihiro Seki, Toll-Like Receptor Signaling and Liver Fibrosis, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  54. 54
    Jan Petrasek, Pranoti Mandrekar, Gyongyi Szabo, Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  55. 55
    Massimo Pinzani, Jose Macias-Barragan, Update on the pathophysiology of liver fibrosis, Expert Review of Gastroenterology & Hepatology, 2010, 4, 4, 459

    CrossRef

  56. 56
    Avlin B. Imaeda, Azuma Watanabe, Muhammad A. Sohail, Shamail Mahmood, Mehdi Mohamadnejad, Fayyaz S. Sutterwala, Richard A. Flavell, Wajahat Z. Mehal, Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome, Journal of Clinical Investigation, 2009,

    CrossRef

  57. 57
    Ariel E. Feldstein, Anna Wieckowska, A. Rocio Lopez, Yao-Chang Liu, Nizar N. Zein, Arthur J. McCullough, Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study, Hepatology, 2009, 50, 4
  58. 58
    Jingjing Jiao, Scott L Friedman, Costica Aloman, Hepatic fibrosis, Current Opinion in Gastroenterology, 2009, 25, 3, 223

    CrossRef

  59. 59
    Hiromi Ishibashi, Minoru Nakamura, Atsumasa Komori, Kiyoshi Migita, Shinji Shimoda, Liver architecture, cell function, and disease, Seminars in Immunopathology, 2009, 31, 3, 399

    CrossRef

  60. 60
    Xinran Ma, Lingyan Xu, Shu Wang, Haoyan Chen, Jianming Xu, Xiaoying Li, Guang Ning, Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis, Laboratory Investigation, 2009, 89, 8, 903

    CrossRef

  61. 61
    Fabio Marra, Sara Aleffi, Sara Galastri, Angela Provenzano, Mononuclear cells in liver fibrosis, Seminars in Immunopathology, 2009, 31, 3, 345

    CrossRef

  62. 62
    Bo Wang, Martin Trippler, Rongjuan Pei, Mengji Lu, Ruth Broering, Guido Gerken, Joerg F. Schlaak, Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication, Journal of Hepatology, 2009, 51, 6, 1037

    CrossRef

  63. 63
    Johannes Kluwe, Ali Mencin, Robert F. Schwabe, Toll-like receptors, wound healing, and carcinogenesis, Journal of Molecular Medicine, 2009, 87, 2, 125

    CrossRef

  64. 64
    Won-Il Jeong, Bin Gao, Innate immunity and alcoholic liver fibrosis, Journal of Gastroenterology and Hepatology, 2008, 23,
  65. 65
    Bin Gao, Won-Il Jeong, Zhigang Tian, Liver: An organ with predominant innate immunity, Hepatology, 2008, 47, 2
  66. 66
    Scott L. Friedman, Mechanisms of Hepatic Fibrogenesis, Gastroenterology, 2008, 134, 6, 1655

    CrossRef

  67. 67
    Natalie J. Török, Recent advances in the pathogenesis and diagnosis of liver fibrosis, Journal of Gastroenterology, 2008, 43, 5, 315

    CrossRef

  68. 68
    Erwin Gäbele, Marcus Mühlbauer, Christoph Dorn, Thomas S. Weiss, Matthias Froh, Bernd Schnabl, Reiner Wiest, Jürgen Schölmerich, Florian Obermeier, Claus Hellerbrand, Role of TLR9 in hepatic stellate cells and experimental liver fibrosis, Biochemical and Biophysical Research Communications, 2008, 376, 2, 271

    CrossRef

  69. 69
    A. Meneghin, E. S. Choi, H. L. Evanoff, S. L. Kunkel, F. J. Martinez, K. R. Flaherty, G. B. Toews, C. M. Hogaboam, TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation, Histochemistry and Cell Biology, 2008, 130, 5, 979

    CrossRef

  70. 70
    Ekihiro Seki, David A. Brenner, Toll-like receptors and adaptor molecules in liver disease: Update, Hepatology, 2008, 48, 1
  71. 71
    Mohammad R. Ebrahimkhani, Ahmed M. Elsharkawy, Derek A. Mann, Wound healing and local neuroendocrine regulation in the injured liver, Expert Reviews in Molecular Medicine, 2008, 10,

    CrossRef

  72. 72
    Natalie J. Torok, Apoptotic cell death takes its toll, Hepatology, 2007, 46, 5
  73. 73
    Gyongyi Szabo, Johanna Bruneau, Hepatic Immunology,
  74. 74
    Stephen H. Caldwell, Curtis K. Argo, Non-Alcoholic Fatty Liver Disease and Nutrition,
  75. 75
    Stephen H. Caldwell, Curtis K. Argo, Abdullah M. S. Al-Osaimi, Nonalcoholic Fatty Liver Disease,